
NYSE:KEYS
This summary was created by AI, based on 1 opinions in the last 12 months.
Keysight Technologies Inc. (KEYS-N) is recognized as a leading measurement company, particularly in the realm of quantum technology, where it plays a critical role in testing chips before their deployment. Experts highlight its position as No. 1 in the quantum platform, emphasizing its importance in facilitating inference-making within the quantum stack. Despite its seemingly high price target of $403, analysts suggest approaching the stock with caution, advising a gradual investment strategy by buying in thirds at prices of $340 and $320. The stock does not offer a dividend yield, and the average analysts' price target hovers around $318.62, indicating some level of pricing disparity that investors should monitor closely.
Keysight Technologies Inc. is a American stock, trading under the symbol KEYS (previously KEYS-N on Stockchase) on the New York Stock Exchange (KEYS). It is usually referred to as NYSE:KEYS or KEYS
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on KEYS (previously KEYS-N on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is TOP PICK. Read the latest stock experts' ratings for Keysight Technologies Inc..
Keysight Technologies Inc. was recommended as a Top Pick by Kim Bolton on 2026-05-06. Read the latest stock experts ratings for Keysight Technologies Inc..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Keysight Technologies Inc..
Keysight Technologies Inc. is followed by 62 investors on Stockchase and is a trending stock that is worth watching.
On 2026-09-04, Keysight Technologies Inc. (KEYS) stock closed at a price of $327.21.
On the platform part of quantum -- middle part of the stack -- helps quantum make inferences. A measurement company, so it's one of the major players testing chips before they get rolled out.
(Analysts’ price target is $318.62)His 12-month price target is $403. May seem pricey, but keep it on your radar. Buy in thirds here, at $340, and at $320. No dividend.